Thiol group control of sodium-lithium countertransport kinetics in uraemia: Evidence of a membrane abnormality affected by haemodialysis

Nephron

Volumn 72, Issue 2, 1996, Pages 184-188

  Rutherford, P A ^a   Thomas, T H ^a   O'kelly J ^a   West, I C ^b   Wilkinson, R ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Erythrocyte; Haemodialysis; Membrane fluidity; N Ethylmaleimide; Sodium lithium countertransport; Sulfhydryl; Thiol; Uraemia

Indexed keywords

LIPID; LITHIUM; MEMBRANE LIPID; N ETHYLMALEIMIDE; SODIUM; THIOL GROUP;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE METABOLISM; FEMALE; HEMODIALYSIS; HUMAN; LIPID BLOOD LEVEL; MALE; MEMBRANE FLUIDITY; PRIORITY JOURNAL; SODIUM TRANSPORT; UREMIA;

AGED; ANTIPORTERS; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; ETHYLMALEIMIDE; FEMALE; HUMANS; ION TRANSPORT; KINETICS; LITHIUM; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; RENAL DIALYSIS; SODIUM; SULFHYDRYL REAGENTS; UREMIA;

EID: 0030067171     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188839     Document Type: Article

References (15)

1. Rutherford PA, Thomas TH, Wilkinson R: Erythrocyte sodium-lithium countertransport: clinically useful, pathophysiologically instructive or just phenomenology? Clin Sei 1992:82: 341-352.
2. Dowd A, Thomas TH, Wilkinson R: Increased human erythrocyte sodium-lithium counter-transport in hvperlipidaemia patients may indicate increased membrane lipid fluidity. Eur J Clin Invest 1993;23:102-107.
3. Dowd A, Thomas TH, Taylor R. Wilkinson R: Erythrocyte sodium-lithium countertransport activity is related to membrane fluidity in IDDM patients. Diabetologia 1994:37:394-400.
4. Woods JW, Parker JC, Watson BS: Perturbation of sodium-lithium countertransport in red cells. N Engl.I Med 1983:308:1258-1261.
5. Corry DB. Tuck ME. Brickman AS. Yanagawa N, Lee DB: Sodium transport in red blood cells from dialyzed uremic patients. Kidney Int 1986:29:1197-1202.
6. Smith JB. Ash KO, Gregory MC. Sprowell WL, Hcntschcl WM. Williams RR: Haemodialysis does not affect erythrocyte sodium-lithium countertransport. Clin Chim Acta 1984:143: 275-279.
7. Quarello F, Boero R, Guarena C, Rosati C, Giraudo G, Giacchino F, Piccoli G: Acute effects of hemodialysis on erythrocyte sodium fluxes in uremic patients. Nephron 1985:41: 22-25.
8. Rutherford PA. Thomas TH, Wilkinson R: Increased erythrocyte sodium-lithium counter-transport activity in essential hypertension is due to an increased affinity for extracellular sodium. Clin Sci 1990:79:365-369.
9. Hardman TC. Sandltu S. Irving F, Lant AF: Characterisation of the erythrocyte sodium-lithium countertransport (SEC) by traditional and kinetic methodologies. Clin Sci 1992: 84(suppl 28):26.
10. Canessa M. Zerbini G: Insulin modulation of Na/Li countertransport: Impact on hypertension and diabetes. Acta Diabetol 1992:29:186-190.
11. Rutherford PA. Thomas TH. Wilkinson R: Characterisation of the response of erythrocyte sodium-lithium countertransport to inhibitors. Biochem Med Mctab Biol 1993:49:270-273.
12. Thomas TH, West IC. Wilkinson R: Thiol group control of erythrocyte Na/Li counter-transport kinetics. Biochim Biophys Acta, in press.
13. Rutherford PA. Thomas TH. Hardman T. Lant AF. Wilkinson R: Sodium-lithium counlertran-sport activity is not affected by short-term insulin exposure in vivo or in a physiological medium in vitro. Metabolism 1993:42:1087-1089.
14. Nosadini R, Sentplicini A. Fioretto P: Na/Li countertransport and cardiorenal abnormalities in essential hypertension. Hypertension 1991:18:191-198.
15. Lindner A, Charra B. Sherrard DJ. Scribner BH: Accelerated atherosclerosis and prolonged maintenance haemodialysis. N Engl J Med 1974:290:697-702.